• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Change Healthcare Acquires PDX

Share:

June 8, 2020

Today, Change Healthcare (Nasdaq: CHNG) announced the acquisition of PDX, a leader in providing patient centric and innovative technologies for pharmacies and health systems.
PDX’s fully integrated retail, specialty, and outpatient pharmacy solutions aim to drive superior operational results for pharmacies while improving outcomes for patients. Their portfolio of solutions includes an Enterprise Pharmacy System™ software, a comprehensive suite of products and services that range from robust data analytics to revenue cycle management, and a flexible clinical services platform.

Today’s transaction complements Change Healthcare’s recent acquisition of eRx Network and demonstrates the company’s continued investment in core aspects of the business to fuel innovation and long-term growth. The combination of Change Healthcare, eRx Network, and PDX will result in faster, more integrated development and cross selling opportunities for Change Healthcare’s combined portfolio of pharmacy network, software, and analytics solutions.

“For over 30 years, PDX has played a critical role in helping pharmacies streamline operations and leverage automation and business intelligence––essential elements in an increasingly competitive retail pharmacy landscape,” said Neil de Crescenzo, president and CEO of Change Healthcare. “Combined with our existing Change Healthcare solutions, we now have a broad portfolio of offerings for pharmacies, an expanded high-quality customer base with significant growth opportunities, and the potential to enter new markets.”

Pharmacies and health systems across the U.S. benefit from technologies and services provided by PDX. Built on a 30-plus year commitment to excellence in healthcare and optimal patient outcomes, PDX has delivered pharmacy and clinical technology solutions that allow pharmacies to process prescriptions, perform reconciliation and adjudication, manage and give authorized caregivers and patients access to healthcare records. This is accomplished through solutions including Absolute AR® revenue cycle management for pharmacies, the PDX pharmacy software management system with applications to assist retail pharmacies with inventory management, clinical programs, and business intelligence, and point of sale solutions.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“After founding PDX with Ron Austring in 1985, PDX has been extremely fortunate to attract a talented group of people to create the Absolute AR®, National Health Information Network® (NHIN), and Freedom Data Systems, Inc.® companies and organizations. Under the leadership of Neil de Crescenzo, the dedicated staff of the PDX companies will continue to serve the pharmacy industry with superior products and services,” said Ken Hill, founder and chairman of the board, PDX Companiesi.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Mesa Labs Acquires Gyros Protein TechnologiesMesa Labs Acquires Gyros Protein Technologies
  • Dot Inc. Releases Braille Display Compatible with iPhones, iPadsDot Inc. Releases Braille Display Compatible with iPhones, iPads
  • RadioMedix Inc. Announces the Acquisition of Its 225Ac-PSMA I&T Program, a Targeted Alpha Therapy (TAT) for Metastatic Castration-resistant Prostate Cancer, By Fusion Pharmaceuticals Inc.RadioMedix Inc. Announces the Acquisition of Its 225Ac-PSMA I&T Program, a Targeted Alpha Therapy (TAT) for Metastatic Castration-resistant Prostate Cancer, By Fusion Pharmaceuticals Inc.
  • Wheel Launches Telehealth Staffing Platform Alongside $13.9M RaiseWheel Launches Telehealth Staffing Platform Alongside $13.9M Raise
  • Healthtech Companies Reap Benefits of Robust Year in Venture Capital FundingHealthtech Companies Reap Benefits of Robust Year in Venture Capital Funding
  • ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic BrandExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand
  • A Matter of Trust: 3 Tips for Outsourcing Out-of-Pocket SupportA Matter of Trust: 3 Tips for Outsourcing Out-of-Pocket Support
  • Signify Health Acquires Healthcare Payment Blockchain Company PatientBloxSignify Health Acquires Healthcare Payment Blockchain Company PatientBlox

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications